Dr. Xu is one of nationally famous cardiologists with good reputation. He is also the chief physician, director of the Heart Center of Shanghai Tenth People's Hospital, director of the Institute of Pan Vascular Diseases, Tongji University School of Medicine, and tenured professor of Tongji University. He was awarded The State Council Special Allowance by National government, also honored the model worker by Shanghai government.
Concurrent academic title:
Chief Scientist of National Key R&D Program
Vice Chairman of Internal Medicine Branch of Chinese Medical Association
Vice President of Cardiovascular Medicine Branch of Chinese Medical Doctor Association
Executive Vice President and Secretary General of Cardiac Rehabilitation Management Committee of Chinese Hospital Association
Chairman of Cardiovascular Medicine Branch of Shanghai Medical Association
Chairman of the Left Atrial Appendage Occlusion Working Committee of the China Atrial Fibrillation Center Alliance
Executive Vice President and Secretary General of the World Association of Chinese Cardiovascular Physicians (WACC)
Vice Chairman of China Chest Pain Center Alliance
Vice Chairman of China Atrial Fibrillation Center Alliance
Vice President of Atrial Fibrillation College of China Atrial Fibrillation Center
Executive Chairman of China Cardiac Rehabilitation Alliance
Executive Chairman of Shanghai Chest Pain Center Alliance …
作为PI主持VIS PMS、TOTAL、VIVE等数项大型国际、国内多中心临床试验。作为亚太地区唯一PI共同主持全球大型多中心临床的TOTAL研究，研究结果作为共同作者发表于《New England Journal of Medicine》（IF= 55.4）。单中心急性心梗院内死亡率仅1.32%，达到国际一流水平。
Dr Yawei Xu has been engaged in clinical and scientific research of cardiovascular disease for more than 30 years, and is proficient in catheter interventional therapy for coronary heart disease, cryoablation of atrial fibrillation, left atrial appendage closure, cardiac physiologic permanent pacemaker implantation, interventional therapy for congenital heart disease, interventional therapy for peripheral artery disease, laser ablation, and rotational atherectomy. He is especially good at the overall treatment of coronary heart disease through the radial artery approach, and has been endeavored to the treatment of acute myocardial infarction for many years.
He is also the chairman or vice chairman of many national medical alliances, which includes Chinese Medical Association Internal Medicine Branch, the Cardiovascular Medicine Branch of the Shanghai Medical Association, Chinese Cardiovascular Physicians in the World Executive Vice President and Secretary General of the Association (WACC), China Chest Pain Center Alliance, China Atrial Fibrillation Center Alliance, etc..
As a PI, Dr Xu presided over several large-scale international and domestic multi-center clinical trials such as VIS PMS, TOTAL, and VIVE. He also co-hosted a global large-scale multi-center clinical TOTAL study as the only PI in Asia-Pacific region, and the results were published as a co-author in the New England Journal of Medicine (IF= 55.4). In the past five years, he has published 351 articles, including 82 SCI articles such as JAMA and JACC, with a cumulative impact factor of nearly 300 points. As the first completer, he won the second prize of 2017" China Medical Science and Technology Award", and won the Shanghai Science and Technology Progress Award, and Shanghai Medical Science and Technology Award for many times. He has served as an evaluation expert in the China Medical Science and Technology Award, and the Shanghai Science and Technology Award for several times. He has also been invited to Hong Kong, Macao, Taiwan, and domestic top conferences for many times as a interventional demonstration guest.